Eyepoint Pharmaceuticals Inc (EYPT) Annual Income Statement (USD)
EYPT Quarterly Financials (USD)
Frequently Asked Questions About Eyepoint Pharmaceuticals Inc (EYPT) Stock
Eyepoint Pharmaceuticals Inc's (EYPT) last reported annual revenue was USD 46.02 Million.
Eyepoint Pharmaceuticals Inc's (EYPT) annual revenue growth rate based on the revenue reported in the past 5 years is : 73.10%
Eyepoint Pharmaceuticals Inc's(EYPT) is not profitable as of its last reported annual financials.
The net profit margin for Eyepoint Pharmaceuticals Inc's(EYPT) from its laster reported year is -153.84%
The return on equity (ROE) for Eyepoint Pharmaceuticals Inc's(EYPT) from its last reported annual financials is : -74.68%
The return on assets (ROA) for Eyepoint Pharmaceuticals Inc's(EYPT) from its last reported annual financials is : -31.39%
The return on invested capital (ROIC) for Eyepoint Pharmaceuticals Inc's(EYPT) from its last reported annual financials is : -37.34%
The Debt to Equity ratio for Eyepoint Pharmaceuticals Inc's(EYPT) from its last reported annual financials is : 0.00%
The dividend yield for Eyepoint Pharmaceuticals Inc's(EYPT) from its laster reported year is 0.00%
Eyepoint Pharmaceuticals Inc's(EYPT) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for EYPT !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
